QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Enters Strategic LOI to Distribute Ketamine Protocol
Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has signed a nonbinding letter of intent with Awakn Life Sciences (NEO: AWKN)(OTCQB: AWKNF). Awakn is a biotechnology company with clinical operations focused on researching, developing and delivering psychedelic medicine to better treat addiction. According to the agreement, MINDCURE will distribute Awakn’s ketamine-assisted psychotherapy for alcohol use disorder protocol via its digital therapeutics platform, iSTRYM. Distribution began in August when MINDCURE released the minimum viable product version of iSTRYM into partner clinics across North America with full commercial deployment to all partner clinics slated for…